1/40
Looks like no tags are added yet.
This bacteria is:
Gram-positive
Has branching filaments, similar to hyphae
Anaerobic, opportunistic
Part of normal oral cavity flora
A. israelii (actinomycosis)
Where can A. israelii be found?
In the oral cavity
What parts of the body is affected by actinomyces?
Initial lesion involves the face/neck
Then involved in chest/abdomen
What gives A. israelii an opportunity to infect?
Mucosal disruption, like trauma or surgery)
What makes actinomyces distinctive?
Draining sinuses that contain sulfur granules
The ‘sulfur’ granules are a distinct yellow color, and are composed of:
Conglomerate of bacteria
Immune cells cemented together with calcium and polysaccharide protein
Clinical features of actinomyces:
Cervicofacial (lumpy jaw, most common location)
Thoracic, abdominal, pelvic
Brain abscesses possible
Chronic, draining lesions
This bacteria is:
Gram-negative
Facultative aerobe
Rod-shaped bacterium
Opportunistic, found in soil and water
HAI (hospital environments)
Flagella motility
Non-fermentive oxidase positive
Produces pigments (green and fluorescent)
Pseudomonas
What two pigments are produced by pseudomonas?
Pyocyanin (blue-green)
Pyoverdine (fluorescent)
Anaerobe or aerobe: pseudomonas?
Facultative aerobe, BUT IS CAPABLE OF ANAEROBIC WITH NITRATE REDUCTION
What allows pseudomonas aeruginosa adhere?
Via pili and flagella, adhering to epithelial cells and fomite surfaces
the biofilm matrix produced by pseudomonas aeruginosa is composed of:
alginate polysaccharides
How does biofilm aid pseudomonas?
Immune evasion
Antibiotic tolerance
What are the 4 toxins produced by pseudomonas?
Exotoxin A
Elastase and alkaline protease
Phospholipase C
Pyocyanin
This toxin produced by pseudomonas is ADP-ribosylates elongation factor 2, halting host protein synthesis
Exotoxin A
This toxin produced by pseudomonas degrades elastin and immunoglobulins.
Elastase and alkaline protease
This toxin produced by pseudomonas disrupts cell membranes and the surfactant in the lungs.
Phospholipase C
This toxin produced by pseudomonas induces oxidative stress and tissue necrosis:
Pyocyanin
What is the secretion system for pseudomonas?
Type III secretion system, injecting effectors (STUY) into host cells
This effector produced by pseudomonas causes rapid tissue necrosis.
ExoU
This effector produced by pseudomonas disrupts the actin cytoskeleton:
ExoS, ExoT
A type VI system contributes to:
bacterial competition and persistance
How do secretion systems aid bacteria?
Gives the bacteria tools to help in the infection progress
How does pseudomonas affect the neutrophils?
Inhibits neutrophil chemotaxis and phagocytosis through alginate shield
How does pseudomonas interfere with cytokine signaling?
Degrades complement proteins, interfering with cytokine signaling
Chronic infection leads to chronic immune response, leading to:
tissue remodeling
Pulmonary manifestations of pseudomonas:
Chronic colonization in cystic fibrosis PTs
Ventilator-associated pneumonia
Skin/soft tissue manifestations of pseudomonas:
Burn wound infections
Folliculitis
Ecthyma gangrenosum
Urinary manifestations of pseudomonas:
Urinary tract infections, via catheter biofilms
Systemic manifestations of psuedomonas:
Bacteremia
Sepsis
(immunocompromised patients, neutropenic patients)
what resistances does pseudomonas have?
Intrinsic
Acquired
Adaptive
Pseudomonas intrinsic resistance:
low membrane permeability
Pseudomonas acquired resistance:
Beta-lactamases (ESBLs carbapenemases)
Pseudomonas adaptive resistance
Biofilm-associated tolerance and quorum testing
Pseudomonas has high morbidity in these areas of the hospital:
Burn units
ICUs
Oncology wards
CF clinics
Pseudomonas is an indicator species for what in hospital systems?
Hospital water system contamination
How is pseudomonas diagnosed?
Blood/MacConkey agar, making specific pigment and smell
Oxidase positive, non-lactose fermenter
MALDI-TOF MS
PCR for virulence, resistance genes and biofilm assays
Combination therapy for pseudomonas:
Antipseudomonal B-lactams
Aminoglycosides
Fluoroquinolones
Novel agents used against pseudomonas:
Ceftolozone-taxobactam, cefiderocol
Experimental therapies used against pseudomonas:
Bacteriophage therapy (prime virus to attack the bacteria)
Quorum-sensing inhibitors
Anti-biofilm peptides